Načítá se...
芦可替尼联合泼尼松、沙利度胺和达那唑治疗骨髓纤维化的探索性研究
OBJECTIVE: To evaluate the efficacy and tolerability of ruxolitinib combined with prednisone, thalidomide and danazol for treatment of in myelofibrosis (MF). METHODS: Patients of MF according to the WHO 2016 criteria, received ruxolitinib (RUX) combined with prednisone, thalidomide and danazol (PTD)...
Uloženo v:
| Vydáno v: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Editorial office of Chinese Journal of Hematology
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7351690/ https://ncbi.nlm.nih.gov/pubmed/30704224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.01.005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|